Danaher Corp.

WKN 866197 ISIN US2358511028

Quote/Chart

  • Bid

    228.1

    600 Units

  • Ask

    228.7

    600 Units

  • Change compared with previous day (price)

    -0.50 / -0.22 %

  • Spread (Act/ Rel)

    0.600 / 0.263 %

  • Today's high (Price)

    229.1

  • Today's low (Price)

    229

Facts & figures

Price data

Trade platform Börse Stuttgart (XSTU)  
Last price 229.1 10 Units
Price determination time 02/21/2024 / 12:05:57 PM
Daily volume (units) 13
Daily high / low 229.1 229
Prev. day's price 229.6 (20.02.)
Change day before -0.5 -0.22 %
52 week high / low 233.3 (19/02) 172.4 (30/10)

Key Figures (in EUR)

2023 2022 2021
Earnings per share 5.90 9.19 7.29
Dividends per share 0.97 0.95 0.71
Dividend Yield in % 0.45% 0.38% 0.26%
Dividend growth in % - -2.09% -25.30%
Price - Earnings ratio 36.26 27.47 38.19
Price - Book ratio 3.20 3.99 5.61
Price - Sales ratio 7.20 6.22 8.23
Price - Cash Flow Ratio 24.00 22.97 29.00

ESG Data

Please log in to see the ESG data for this stock.

Not registered yet? Create an account here.

Master Data

WKN
866197
ISIN
US2358511028
Symbol
DAP
Exchange segment
Open Market
Type of financial instrument
Equity
Denomination
Danaher
Index membership
-
Trading segment
-
Trading hours
08:00:00 - 22:00:00
Trading currency
Euro
Nominal currency
US Dollar
Settlement currency
Euro
Sector and industry
Technology, Electrotechnology
Number of shares
739.20 Mil.
Market capitalisation
169.72 Bil.

Performance overview

1W 1M 3M 6M 1Y 3Y 5Y YTD
Performance 1.95% 10.33% 19.06% 12.30% 8.55% 36.02% 165.50% 9.18%
High 233.30 233.30 233.30 233.30 233.30 262.86 262.86 233.30
Low 223.50 207.50 194.00 172.40 172.40 157.19 86.45 204.70

Company profile

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.